𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clodronate (Bonefos®) in the management of glucocorticoid-induced osteoporosis

✍ Scribed by H. Puolijoki; J. Herrala; K. Liippo; M. Raitio; O. Impivaara; M. M. Nieminen; E. Tala

Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
130 KB
Volume
6
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Barriers in the management of glucocorti
Barriers in the management of glucocorticoid-induced osteoporosis
✍ Guzman-Clark, Jenice Ria S. ;Fang, Meika A. ;Sehl, Mary E. ;Traylor, Laural ;Hah 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Objective To determine present practice for the management of glucocorticoid‐induced osteoporosis (GIOP) in veterans; to characterize provider knowledge, beliefs, and practice behaviors regarding management of GIOP; and to identify potential barriers and interventions in the managem

Uncertainties in the prevention and trea
Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis
✍ Karen E Hansen; H Alexander Wilson; Carol Zapalowski; Howard A Fink; Salvatore M 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 96 KB

## Abstract Much knowledge has accrued since the 2001 American College of Rheumatology (ACR) guidelines were published to assist clinicians in the prevention and treatment of glucocorticoid‐induced osteoporosis (GIO). Therefore, the ACR undertook a comprehensive effort to review the literature and